Related Experiment Video
Updated: Jun 25, 2026

15:28
Engineering Adherent Bacteria by Creating a Single Synthetic Curli Operon
Published on: November 16, 2012
Application of colicin E1 as a prefabrication intervention strategy
Brenda S Patton1, Steven M Lonergan, Sara A Cutler
1Food Safety Research Laboratory, Department of Food Science and Human Nutrition, Iowa State University, Ames, Iowa 50011, USA.
Journal of Food Protection
|February 28, 2009
Summary
Colicin E1 (ColE1) effectively controlled E. coli O157:H7 contamination on beef. This bacteriocin shows promise as a food safety intervention, significantly reducing pathogen levels on beef carcasses.
Area of Science:
- Food Science
- Microbiology
- Bacteriology
Background:
- Escherichia coli O157:H7 is a significant foodborne pathogen.
- Controlling E. coli O157:H7 on beef carcasses is crucial for public health.
- Bacteriocins, like Colicin E1 (ColE1), offer potential antimicrobial strategies.
Purpose of the Study:
- To evaluate Colicin E1 (ColE1) as an intervention to control E. coli O157:H7 on beef carcasses.
- To determine the efficacy of different ColE1 concentrations in reducing E. coli O157:H7 contamination.
- To assess the persistence of ColE1's inhibitory effect over time.
Main Methods:
- Beef round roasts were inoculated with E. coli O157:H7.
- Samples were sprayed with varying doses of ColE1 (0, 100 µg, 500 µg, 1 mg/ml).
- E. coli O157:H7 levels were quantified over 5 days at 10°C.
Main Results:
- ColE1 treatments at 500 µg and 1 mg/ml significantly inhibited E. coli O157:H7 growth.
- E. coli O157:H7 contamination was reduced by 4 and 7 log CFU/cm², respectively, with these doses.
- A 1 mg/ml dose of ColE1 provided significant inhibition throughout the 5-day study period.
Conclusions:
- Colicin E1 is a potent agent for reducing E. coli O157:H7 on beef carcasses.
- ColE1 demonstrates potential as a novel food safety intervention strategy.
- Further research into ColE1 application methods for meat products is warranted.
Related Concept Videos
Antibiotic Selection
Overview
Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
Production of Antibiotics
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...

